Tracy Ann Vivlemore

Array ( [id] => 19067603 [patent_doc_number] => 20240102029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST [patent_app_type] => utility [patent_app_number] => 18/301240 [patent_app_country] => US [patent_app_date] => 2023-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19067603 [patent_doc_number] => 20240102029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST [patent_app_type] => utility [patent_app_number] => 18/301240 [patent_app_country] => US [patent_app_date] => 2023-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18139388 [patent_doc_number] => 20230013224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use [patent_app_type] => utility [patent_app_number] => 17/748767 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17655348 [patent_doc_number] => 20220175813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/676811 [patent_app_country] => US [patent_app_date] => 2022-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38625 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18034611 [patent_doc_number] => 20220378826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/570556 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35288 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18034611 [patent_doc_number] => 20220378826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/570556 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35288 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17998057 [patent_doc_number] => 11499153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Nucleic acids for inhibiting expression of LPA in a cell [patent_app_type] => utility [patent_app_number] => 17/559479 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 29 [patent_no_of_words] => 34851 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17911340 [patent_doc_number] => 20220313735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES [patent_app_type] => utility [patent_app_number] => 17/550737 [patent_app_country] => US [patent_app_date] => 2021-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18842627 [patent_doc_number] => 20230405031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => METHODS AND COMPOSITIONS RELATED TO RECEPTOR-MEDIATED GLUCOSE SENSING [patent_app_type] => utility [patent_app_number] => 18/037929 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17875520 [patent_doc_number] => 11447521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Compounds and methods for modulating angiotensinogen expression [patent_app_type] => utility [patent_app_number] => 17/529897 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32017 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17412617 [patent_doc_number] => 20220047521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => Drug Delivery Particle and Method for Producing the Same [patent_app_type] => utility [patent_app_number] => 17/516917 [patent_app_country] => US [patent_app_date] => 2021-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17516917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17587908 [patent_doc_number] => 11326166 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-05-10 [patent_title] => Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/505732 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 75294 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17713674 [patent_doc_number] => 11377658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-05 [patent_title] => Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases [patent_app_type] => utility [patent_app_number] => 17/476317 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77965 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17665518 [patent_doc_number] => 11359199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 17/411789 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 43 [patent_no_of_words] => 32665 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17527064 [patent_doc_number] => 11299737 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-12 [patent_title] => Compounds and methods for modulating SMN2 [patent_app_type] => utility [patent_app_number] => 17/356961 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31009 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19361141 [patent_doc_number] => 20240263175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => COMPOSITION FOR TREATING METASTATIC SOLID CANCER, COMPRISING TSG6 INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/010832 [patent_app_country] => US [patent_app_date] => 2021-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17256772 [patent_doc_number] => 20210369757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/346556 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38592 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18690961 [patent_doc_number] => 20230321135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => TARGETING OF LACTATE DEHYDROGENASE C, METHODS OF PREPARING SAME, AND METHODS OF USING SAME IN COMBINATION WITH ANTI-CANCER TREATMENTS [patent_app_type] => utility [patent_app_number] => 18/009245 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9600 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17657443 [patent_doc_number] => 20220177908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => RECOMBINANT NUCLEIC ACID MOLECULE OF TRANSCRIPTIONAL CIRCULAR RNA AND ITS APPLICATION IN PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 17/337612 [patent_app_country] => US [patent_app_date] => 2021-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17236885 [patent_doc_number] => 11180757 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-11-23 [patent_title] => 17b-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/321001 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 90345 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17321001 [rel_patent_id] =>[rel_patent_doc_number] =>)